These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8628523)

  • 21. THE PATIENT-DOCTOR-PSYCHOLOGIST TRIANGLE IN A CASE Of SEVERE IMUNOSUPRESSION IN THE HIV INFECTION.
    Manciuc C; Filip-Ciubotaru F; Badescu A; Duceag LD; Largu AM
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):119-23. PubMed ID: 27125083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The global fight against AIDS--are we advancing or retreating?].
    Handzel ZT
    Harefuah; 1993 Oct; 125(7-8):251-3. PubMed ID: 8225117
    [No Abstract]   [Full Text] [Related]  

  • 23. Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection.
    O'Neal CB; Ball SC
    AIDS Read; 2008 Oct; 18(10):503-8. PubMed ID: 18975440
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 26. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection.
    Rose EW; McCloskey WW
    Ann Pharmacother; 1998 Mar; 32(3):381-3. PubMed ID: 9533069
    [No Abstract]   [Full Text] [Related]  

  • 27. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
    Miller RF
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
    [No Abstract]   [Full Text] [Related]  

  • 28. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
    James CW; McNelis KC; Szabo S
    Am J Health Syst Pharm; 2003 Aug; 60(15):1572-4. PubMed ID: 12951757
    [No Abstract]   [Full Text] [Related]  

  • 29. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus.
    Phair JP; Masur H; Gross PA; Holmes KK; Kaplan JE
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S128-9. PubMed ID: 8547504
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain abscesses in HIV-positive patients due to Pneumocystis jiroveci.
    Nasnas R; Matta MY; El Helou G; Rizk N; Sarkis DK; Moussa R
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):169-71. PubMed ID: 22453876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of hyperdynamic shock caused by trimethoprim-sulfamethoxazole in which no tumor necrosis factor or features of anaphylaxis were detected.
    Nguyen BY; Landucci DL; Cunnion RE; Yarchoan R; Walker RE
    Clin Infect Dis; 1993 Nov; 17(5):885-7. PubMed ID: 8286631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
    Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
    Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
    [No Abstract]   [Full Text] [Related]  

  • 33. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
    Morris-Jones SD; Easterbrook PJ
    J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
    [No Abstract]   [Full Text] [Related]  

  • 34. Pneumocystis carinii choroidopathy and aerosolized pentamidine prophylaxis in a patient with AIDS.
    Lalonde L; Allaire GS; Sebag M; Lamer L; Marcil G; Gervais A
    Can J Ophthalmol; 1993 Oct; 28(6):291-3. PubMed ID: 8299056
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.
    Rodriguez M; Fishman JA
    Clin Microbiol Rev; 2004 Oct; 17(4):770-82, table of contents. PubMed ID: 15489347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
    Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
    Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
    Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and economic aspects of prophylaxis and treatment of Pneumocystis carinii pneumonia.
    Freedberg KA
    Pharmacoeconomics; 1995 Feb; 7(2):95-8. PubMed ID: 10155305
    [No Abstract]   [Full Text] [Related]  

  • 40. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.